BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21794028)

  • 1. Enhancement of B-cell receptor signaling by a point mutation of adaptor protein 3BP2 identified in human inherited disease cherubism.
    Ogi K; Nakashima K; Chihara K; Takeuchi K; Horiguchi T; Fujieda S; Sada K
    Genes Cells; 2011 Sep; 16(9):951-60. PubMed ID: 21794028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphorylation of 3BP2 is indispensable for the interaction with VAV3 in chicken DT40 cells.
    Chihara K; Kimura Y; Honjoh C; Yamauchi S; Takeuchi K; Sada K
    Exp Cell Res; 2014 Mar; 322(1):99-107. PubMed ID: 24406398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Point mutations of 3BP2 identified in human-inherited disease cherubism result in the loss of function.
    Miah SM; Hatani T; Qu X; Yamamura H; Sada K
    Genes Cells; 2004 Nov; 9(11):993-1004. PubMed ID: 15507112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine phosphorylation of 3BP2 regulates B cell receptor-mediated activation of NFAT.
    Shukla U; Hatani T; Nakashima K; Ogi K; Sada K
    J Biol Chem; 2009 Dec; 284(49):33719-28. PubMed ID: 19833725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptor protein 3BP2 and cherubism.
    Hatani T; Sada K
    Curr Med Chem; 2008; 15(6):549-54. PubMed ID: 18336269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
    Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
    Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor.
    Foucault I; Le Bras S; Charvet C; Moon C; Altman A; Deckert M
    Blood; 2005 Feb; 105(3):1106-13. PubMed ID: 15345594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SH3BP2 cherubism mutation potentiates TNF-α-induced osteoclastogenesis via NFATc1 and TNF-α-mediated inflammatory bone loss.
    Mukai T; Ishida S; Ishikawa R; Yoshitaka T; Kittaka M; Gallant R; Lin YL; Rottapel R; Brotto M; Reichenberger EJ; Ueki Y
    J Bone Miner Res; 2014 Dec; 29(12):2618-35. PubMed ID: 24916406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism.
    Levaot N; Voytyuk O; Dimitriou I; Sircoulomb F; Chandrakumar A; Deckert M; Krzyzanowski PM; Scotter A; Gu S; Janmohamed S; Cong F; Simoncic PD; Ueki Y; La Rose J; Rottapel R
    Cell; 2011 Dec; 147(6):1324-39. PubMed ID: 22153076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptor function for the Syk kinases-interacting protein 3BP2 in IL-2 gene activation.
    Deckert M; Tartare-Deckert S; Hernandez J; Rottapel R; Altman A
    Immunity; 1998 Nov; 9(5):595-605. PubMed ID: 9846481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The autoinhibitory C-terminal SH2 domain of phospholipase C-γ2 stabilizes B cell receptor signalosome assembly.
    Wang J; Sohn H; Sun G; Milner JD; Pierce SK
    Sci Signal; 2014 Sep; 7(343):ra89. PubMed ID: 25227611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SHP-1 dephosphorylates 3BP2 and potentially downregulates 3BP2-mediated T cell antigen receptor signaling.
    Yu Z; Maoui M; Zhao ZJ; Li Y; Shen SH
    FEBS J; 2006 May; 273(10):2195-205. PubMed ID: 16649996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swiprosin-1/EFhd2 controls B cell receptor signaling through the assembly of the B cell receptor, Syk, and phospholipase C gamma2 in membrane rafts.
    Kroczek C; Lang C; Brachs S; Grohmann M; Dütting S; Schweizer A; Nitschke L; Feller SM; Jäck HM; Mielenz D
    J Immunol; 2010 Apr; 184(7):3665-76. PubMed ID: 20194721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BASH, a novel signaling molecule preferentially expressed in B cells of the bursa of Fabricius.
    Goitsuka R; Fujimura Y; Mamada H; Umeda A; Morimura T; Uetsuka K; Doi K; Tsuji S; Kitamura D
    J Immunol; 1998 Dec; 161(11):5804-8. PubMed ID: 9834055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syk-dependent tyrosine phosphorylation of 3BP2 is required for optimal FcRγ-mediated phagocytosis and chemokine expression in U937 cells.
    Chihara K; Kato Y; Yoshiki H; Takeuchi K; Fujieda S; Sada K
    Sci Rep; 2017 Sep; 7(1):11480. PubMed ID: 28904407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The adaptor protein 3BP2 in leukocyte signaling].
    Deckert M
    Med Sci (Paris); 2006 Dec; 22(12):1081-6. PubMed ID: 17156730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3BP2 deficiency impairs the response of B cells, but not T cells, to antigen receptor ligation.
    de la Fuente MA; Kumar L; Lu B; Geha RS
    Mol Cell Biol; 2006 Jul; 26(14):5214-25. PubMed ID: 16809760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kinase Syk as an adaptor controlling sustained calcium signalling and B-cell development.
    Kulathu Y; Hobeika E; Turchinovich G; Reth M
    EMBO J; 2008 May; 27(9):1333-44. PubMed ID: 18369315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cbl-b positively regulates Btk-mediated activation of phospholipase C-gamma2 in B cells.
    Yasuda T; Tezuka T; Maeda A; Inazu T; Yamanashi Y; Gu H; Kurosaki T; Yamamoto T
    J Exp Med; 2002 Jul; 196(1):51-63. PubMed ID: 12093870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The adaptor 3BP2 activates CD244-mediated cytotoxicity in PKC- and SAP-dependent mechanisms.
    Saborit-Villarroya I; Martinez-Barriocanal A; Oliver-Vila I; Engel P; Sayos J; Martin M
    Mol Immunol; 2008 Jul; 45(12):3446-53. PubMed ID: 18479751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.